Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Study Reveals a Glass of Milk a Day Could Help Lower Women's Risk of Colorectal Cancer
A new study found that getting a glass of milk's worth of calcium per day, whether or not it comes from dairy, can lower colorectal cancer risk in women. Here's why.
This Refrigerator Staple Might Lower a Woman's Risk of Colorectal Cancer, New Study Says
A new study from the Oxford University and Cancer Research UK, which was published in 'Nature,' found that the amount of calcium in a large glass of milk lowers a woman’s risk of developing colorectal cancer by 17%.
A glass of milk's worth of calcium has been linked to a lower colorectal cancer risk. Here are 6 foods you might not know contain the mineral.
In a study of 542,000 women, consuming the amount of calcium found in a glass of milk a day was linked to a lower colorectal cancer risk Foods such as figs and tofu also contain the mineral.
This drug can lower risk of colorectal cancer by 18%
Study of 107,000 participants demonstrates regular aspirin use significantly reduces colorectal cancer risk, especially in individuals with unhealthy lifestyles
Worried about colorectal cancer? Study recommends have a glass of milk every day
Colorectal cancer affects millions of people on earth, and is one of the most common types of cancer. However, with the right kind of diet, it is possible to take precautionary measures against the development of this aggressive type of cancer.
Why a daily glass of milk really could reduce bowel cancer risk — an oncologist explains
"[In addition], reducing consumption of alcohol and red and processed meat could also help protect against cancer"
Expert Explains Why a Glass of Milk Each Day Could Slash Cancer Risk
A glass of milk a day could help keep bowel cancer away – or so finds a study by Oxford University and Cancer Research UK.
CNET
1d
Colon Cancer: Signs, Risk Factors and How to Reduce Your Likelihood
Exercise: Regular exercise can help maintain a healthy body and weight, which lowers the risk of colon cancer. Aim for 150 ...
Cure Today
12h
Carrying the Torch: From Colorectal Cancer Survivor to Advocate
As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their ...
Hosted on MSN
1d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
"The trial shows that aspirin is well tolerated in this patient group but does not demonstrate a significant reduction in ...
Healio
12h
FDA approves therapies for colorectal cancer, mantle cell lymphoma
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...
10d
on MSN
I was diagnosed with stage 3 colon cancer at 44 — the 5 symptoms I ignored
In 2012, at the age of 44, was diagnosed with stage 3c colon cancer. Since then, she has been an advocate for awareness on TikTok.
1d
on MSN
US FDA approves Amgen's colorectal cancer therapy
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...
The American Journal of Managed Care
1d
Prioritizing Blood-Based Colorectal Cancer Tests May Lead to Higher Costs, Worse Outcomes
Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in ...
Rolling Out
9d
FIT test revolutionizes colorectal cancer screening
Discover how the FIT test is transforming colorectal cancer screening, reducing mortality rates and offering a more ...
14h
on MSN
Having this body shape means you’re more at risk for colorectal cancer, diabetes and heart disease
Research shows that people with a certain body shape face a higher risk of serious health problems compared to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Singapore
Panitumumab
Food and Drug Administration
Amgen
Lumakras
Feedback